1-3 of 3
Carmen Blanco
Close
Sort by
Journal Articles

PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma

Cristina Gómez-Abad, Helena Pisonero, Carmen Blanco-Aparicio, Giovanna Roncador, Alberto González-Menchén, Jose A. Martinez-Climent, Eva Mata, María Elena Rodríguez, Guillermo Muñoz-González, Margarita Sánchez-Beato, Juan F. Leal, James R. Bischoff, Miguel A. Piris
Journal: Blood
Blood (2011) 118 (20): 5517–5527.
https://doi.org/10.1182/blood-2011-03-344374
Published: 2011
Includes: Supplemental data
Journal Articles

Pharmacological Inhibition of PIM Kinases In Chronic Lymphocytic Leukemia Cases with Unfavorable Prognosis Markers

Beatriz Herreros, James R. Bischoff, Maria E. Rodriguez, Margarita Sanchez-Beato, Elena Domenech, Carmen Blanco, Cristina I. Gomez-Abad, Raul Cordoba, Julio Delgado, Jose A Garcia-Marco, MD, PhD, Juan F. Garcia, José Francisco Tomás, Joaquín Martínez-López, Antonia Rodriguez, Raquel Villuendas, Miguel A. Piris
Journal: Blood
Blood (2010) 116 (21): 2468.
https://doi.org/10.1182/blood.V116.21.2468.2468
Published: 2010
Journal Articles

PIM as a Rational Target for B-Cell Lymphomas.

Cristina Gomez-Abad, PhD, Helena Pisonero, Juan F Leal, PhD, Giovanna Roncador, Jose A. Martinez-Climent, MD, PhD, Margarita Sánchez-Beato, PhD, Carmen Blanco-Aparicio, PhD, James Robert Bischoff, PhD, Miguel A. Piris, MD
Journal: Blood
Blood (2009) 114 (22): 3946.
https://doi.org/10.1182/blood.V114.22.3946.3946
Published: 2009